Could Palmitoylethanolamide Be an Effecti... - Cure Parkinson's

Cure Parkinson's

25,550 members26,870 posts

Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19?

Bolt_Upright profile image
1 Reply

Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications innovationscns.com/palmitoy...

"Conclusion

Available data suggest that PEA could be an optimal therapy to fight inflammation caused by COVID-19 by mitigating the cytokine storm in these frail patients without adverse events. Indeed, the compound has the advantage of not weakening, but positively modulating, cell-mediated immunity, as do immunosuppressive agents, such as corticosteroids or tocilizumab."

Considering how Covid makes PD worse, and how some people seem to think Long Covid may be PD, seems like PEA might be a good thing to be on or have handy.

Written by
Bolt_Upright profile image
Bolt_Upright
To view profiles and participate in discussions please or .
Read more about...
1 Reply
beehive23 profile image
beehive23

ill ask the folks at my long covid clinic...hang tough.

You may also like...

Vitamin D & Covid-19 : Possible link between the two?

scientific study about the positive link between Covid-19 and Vitamin D is sparking further......

Is there a link between attitudes to covid vaccination and the rejection of conventional medicine in the treatment of PD?

respond to one of Marc's posts about the lack of covid data in the USA with this guardian article...

Here is a supplement, PEA, that Parkinson's News Today says works well for PWP

reduced after one year of um-PEA treatment,” they reported, concluding that “um-PEA may be an...

Hydroxychloroquine was administered at a nursing home for Covid-19. No death and no side effects for all 39 of the elderly patients treated.

first big tests of hydroxychloroquine to treat COVID-19 patients in Texas. “I thought the...

Covid 19 may infect dopamine neurons

surprising to me https://neurosciencenews.com/dopamine-covid-25475/